[{"id":"ee2359d4-314f-402b-b016-07b5131d6e97","acronym":"","url":"https://clinicaltrials.gov/study/NCT00150072","created_at":"2021-01-18T23:14:50.146Z","updated_at":"2024-07-02T16:37:25.097Z","phase":"Phase 2","brief_title":"Efficacy and Safety of Imatinib in Chordoma","source_id_and_acronym":"NCT00150072","lead_sponsor":"Novartis Pharmaceuticals","biomarkers":" PDGFRB • PDGFB","pipe":"","alterations":" ","tags":["PDGFRB • PDGFB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e imatinib"],"overall_status":"Completed","enrollment":" Enrollment 55","initiation":"Initiation: 10/01/2004","start_date":" 10/01/2004","primary_txt":" Primary completion: 04/01/2008","primary_completion_date":" 04/01/2008","study_txt":" Completion: 04/01/2008","study_completion_date":" 04/01/2008","last_update_posted":"2017-02-23"}]